Drug Plan Management, Prescription Drugs Canadian Insurer details on coverage for Wegovy for cardiovascular treatment February 1, 2025 GroupForce Benefit News January 2025 Tags: Canada, Cardiovascular indication, Insurance, semaglutide, Wegovy, weight loss What do you think? Show comments / Leave a comment Insights More Related Articles Media The Benefits Alliance welcomes Human Capital Benefits as a Member FIrm Advise, Announcements, Benefit Satisfaction Surveys, Report, The Workplace Human Capital Benefits Benchmarking Tool – Coming Soon Media Canadian Leadership Council on Drug Plan Partnerships
